FSCN1 as a Candidate Gene for Syndromic Intellectual Disability? Evidence From a Recurrent Variant in an Iranian Cohort
Clinical Genetics · 2026
DOI: 10.1111/cge.70051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Hossein Najmabadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Intellectual Disability, Microfilament Proteins, Carrier Proteins, Genetic Predisposition to Disease. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Iran National Science Foundation.
Abstract (Originalsprache)
Intellectual disability (ID) is a genetically heterogeneous disorder, and many causative genes remain unidentified. FSCN1 encodes an actin‐bundling protein essential for neuronal development, but its role in human neurodevelopmental disorders has not been clinically established. By revisiting data from a previously studied Iranian ID cohort, we identified two unrelated families carrying the same rare pathogenic missense variant in FSCN1 (c.665C>A; p.Ala222Asp). Affected individuals exhibited moderate to severe ID with consistent craniofacial features, including a prominent maxilla, long face, broad forehead, and thick lower lip. In silico tools predicted the variant as damaging and destabilizing, and the affected residue is highly conserved. This study provides the first clinical evidence linking FSCN1 to syndromic ID with craniofacial anomalies. The craniofacial features observed in our patients are consistent with experimental evidence from animal models. Together with supportive data from animal models, our findings suggest FSCN1 as a candidate gene for rare or ultra‐rare forms of ID and warrant further functional studies to elucidate its precise pathogenic mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
ORCID-Profile: Hossein Najmabadi, Kimia Kahrizi
Förderung
- Iran National Science Foundation
Zitieren
APA
Najmabadi, H., Akhtarkhavari, T., Shokouhian, E., Arzhangi, S., & Kahrizi, K. (2026). FSCN1 as a Candidate Gene for Syndromic Intellectual Disability? Evidence From a Recurrent Variant in an Iranian Cohort. Clinical Genetics. https://doi.org/10.1111/cge.70051
Vancouver
Najmabadi H, Akhtarkhavari T, Shokouhian E, Arzhangi S, Kahrizi K. FSCN1 as a Candidate Gene for Syndromic Intellectual Disability? Evidence From a Recurrent Variant in an Iranian Cohort. Clinical Genetics. 2026. doi:10.1111/cge.70051
BibTeX
@article{Najmabadi2026,
author = {Najmabadi, Hossein and Akhtarkhavari, Tara and Shokouhian, Ebrahim and Arzhangi, Sanaz and Kahrizi, Kimia},
title = {FSCN1 as a Candidate Gene for Syndromic Intellectual Disability? Evidence From a Recurrent Variant in an Iranian Cohort},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70051}
}
EUVIMED